IPCA Laboratories shares dropped 2.8% after Nomura and HSBC Research lowered their price targets due to revised revenue growth guidance and potential margin pressures. Despite recent profit gains, the stock is down 18.3% YTD with high trading volume.
India's NABARD to Issue $2.3B Deep-Discount Bonds by 2027
Asia's Gold Demand Slumps Amid High Prices and Rates
ITD Cementation Soars 6.93% on Rs 893 Crore Order
IndiGo Stake Sale Aims to Raise $1B Amid Market Turmoil
Adani Ports Stock Falls Amid Middle East Tensions
HDFC Bank Q3 FY26 Highlights
Ircon International Wins ₹2.54B Railway Order
News that matters the most ⚡